Vol.

No.

January 21, 2022Jan 21, 2022

DOWNLOAD THE PDF

Robert Stone: How City of Hope will go national through acquisition of Cancer Treatment Centers of America

Cover Story

Conversation with The Cancer Letter

Robert Stone: How City of Hope will go national through acquisition of Cancer Treatment Centers of America

By Paul Goldberg

The acquisition of Cancer Treatment Centers of America will allow City of Hope to build a national network of cancer centers that is fundamentally different from those of other cancer centers.

CPRIT scientists: We do not accept Texas’ harmful COVID policies, attack on women’s reproductive rights

By Matthew Bin Han Ong

To combat IP theft, NIH strengthens disclosure requirements for grant recipients

By Alice Tracey

Free Guest Editorial

Congress, Biden have an opportunity to invest in cancer research today for better treatments, cures tomorrow

By David A. Tuveson

Free In the Archives

The Institute for Drug Development and an archive of institutional histories

In Brief

M. Eileen Dolan named deputy director of UChicago Medicine Comprehensive Cancer Center

Moncrief Cancer Institute awarded $9M for cancer screening program for underserved residents

David Smith, Shruti Jolly named to leadership positions at U-M Rogel Cancer Center

Shusen Liu named chief medical officer of GenomiCare Biotechnology

Funding Opportunities

ALK Positive, LUNGevity Foundation issue RFA for lung cancer research award program

DOD Lung Cancer Research Program announces anticipated funding opportunities for FY22

Clinical Roundup

KEYNOTE-775 study shows Keytruda + Lenvima improves survival in advanced endometrial carcinoma

Imfinzi + tremelimumab improves OS in first-line unresectable HCC, with 31% of patients alive at three years

Second-generation Cologuard test shows improved accuracy for colorectal cancer screening

UC Davis study: Latino smokers in California on Medi-Cal still not getting help needed to quit

Fox Chase study: Head and neck cancer incidence disparities driven by risk factors, not race

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

MD Anderson and Yingli Pharma collaborate to advance development of multiple oncology programs

TriSalus, UColorado Anschutz Medical Campus to collaborate on immuno-oncology treatments for liver and pancreatic tumors

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues